BDMD (Baird Medical Investment Holdings) Effective Interest Rate on Debt % : 3.54% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Baird Medical Investment Holdings's annualized positive value of Interest Expense for the quarter that ended in Jun. 2024 was $0.48 Mil. Baird Medical Investment Holdings's average total debt for the quarter that ended in Jun. 2024 was $13.52 Mil. Therefore, Baird Medical Investment Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 was 3.54%.

Baird Medical Investment Holdings Effective Interest Rate on Debt % Historical Data

The historical data trend for Baird Medical Investment Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Effective Interest Rate on Debt % Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

5.25

5.76

3.02

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Effective Interest Rate on Debt %	-	-	2.23	3.51	3.54

Competitive Comparison of Baird Medical Investment Holdings's Effective Interest Rate on Debt %

For the Medical Devices subindustry, Baird Medical Investment Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baird Medical Investment Holdings's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Baird Medical Investment Holdings Effective Interest Rate on Debt % Calculation

Baird Medical Investment Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -0.286	/	( (7.441	+	11.514)	/ 2 )
=	-1 * -0.286	/	9.4775
=	3.02 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.817	+	6.624
=	7.441

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.026	+	9.488
=	11.514

Baird Medical Investment Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2023 )	+	Total Debt (Q: Jun. 2024 ))	/ count )
=	-1 * -0.478	/	( (11.514	+	15.517)	/ 2 )
=	-1 * -0.478	/	13.5155
=	3.54 %

where

	Total Debt (Q: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	2.026	+	9.488
=	11.514

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	1.351	+	14.166
=	15.517

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Baird Medical Investment Holdings (NAS:BDMD) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Baird Medical Investment Holdings Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.